Hutchinson JN, Muller WJ: Transgenic mouse models of human breast cancer. Oncogene. 2000, 19: 6130-6137. 10.1038/sj.onc.1203970.
Article
CAS
PubMed
Google Scholar
Gunther EJ, Moody SE, Belka GK, Hahn KT, Innocent N, Dugan KD, Cardiff RD, Chodosh LA: Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis. Genes Dev. 2003, 17: 488-501. 10.1101/gad.1051603.
Article
CAS
PubMed
PubMed Central
Google Scholar
D'Cruz CM, Gunther EJ, Boxer RB, Hartman JL, Sintasath L, Moody SE, Cox JD, Ha SI, Belka GK, Golant A, Cardiff RD, Chodosh LA: c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat Med. 2001, 7: 235-239. 10.1038/84691.
Article
PubMed
Google Scholar
Moody SE, Sarkisian CJ, Hahn KT, Gunther EJ, Pickup S, Dugan KD, Innocent N, Cardiff RD, Schnall MD, Chodosh LA: Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis. Cancer Cell. 2002, 2: 451-461. 10.1016/S1535-6108(02)00212-X.
Article
CAS
PubMed
Google Scholar
Desai KV, Xiao N, Wang W, Gangi L, Greene J, Powell JI, Dickson R, Furth P, Hunter K, Kucherlapati R, Simon R, Liu ET, Green JE: Initiating oncogenic event determines gene-expression patterns of human breast cancer models. Proc Natl Acad Sci U S A. 2002, 99: 6967-6972. 10.1073/pnas.102172399.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cardiff RD, Muller WJ: Transgenic mouse models of mammary tumorigenesis. Cancer Surv. 1993, 16: 97-113.
CAS
PubMed
Google Scholar
Cardiff RD, Sinn E, Muller W, Leder P: Transgenic oncogene mice. Tumor phenotype predicts genotype. Am J Pathol. 1991, 139: 495-501.
CAS
PubMed
PubMed Central
Google Scholar
Cardiff RD, Munn RJ: Comparative pathology of mammary tumorigenesis in transgenic mice. Cancer Lett. 1995, 90: 13-19. 10.1016/0304-3835(94)03672-6.
Article
CAS
PubMed
Google Scholar
Li Y, Welm B, Podsypanina K, Huang S, Chamorro M, Zhang X, Rowlands T, Egeblad M, Cowin P, Werb Z, Tan LK, Rosen JM, Varmus HE: Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci U S A. 2003, 100: 15853-15858. 10.1073/pnas.2136825100.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kwan H, Pecenka V, Tsukamoto A, Parslow TG, Guzman R, Lin TP, Muller WJ, Lee FS, Leder P, Varmus HE: Transgenes expressing the Wnt-1 and int-2 proto-oncogenes cooperate during mammary carcinogenesis in doubly transgenic mice. Mol Cell Biol. 1992, 12: 147-154.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kapoun AM, Shackleford GM: Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice. Oncogene. 1997, 14: 2985-2989. 10.1038/sj.onc.1201146.
Article
CAS
PubMed
Google Scholar
Shackleford GM, MacArthur CA, Kwan HC, Varmus HE: Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt-1 transgenic mice by insertional activation of int-2/Fgf-3 and hst/Fgf-4. Proc Natl Acad Sci U S A. 1993, 90: 740-744.
Article
CAS
PubMed
PubMed Central
Google Scholar
MacArthur CA, Shankar DB, Shackleford GM: Fgf-8, activated by proviral insertion, cooperates with the Wnt-1 transgene in murine mammary tumorigenesis. J Virol. 1995, 69: 2501-2507.
CAS
PubMed
PubMed Central
Google Scholar
Donehower LA, Godley LA, Aldaz CM, Pyle R, Shi YP, Pinkel D, Gray J, Bradley A, Medina D, Varmus HE: Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes Dev. 1995, 9: 882-895.
Article
CAS
PubMed
Google Scholar
Li Y, Podsypanina K, Liu X, Crane A, Tan LK, Parsons R, Varmus HE: Deficiency of Pten accelerates mammary oncogenesis in MMTV-Wnt-1 transgenic mice. BMC Mol Biol. 2001, 2: 2-10.1186/1471-2199-2-2.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sinn E, Muller W, Pattengale P, Tepler I, Wallace R, Leder P: Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell. 1987, 49: 465-475. 10.1016/0092-8674(87)90449-1.
Article
CAS
PubMed
Google Scholar
Siegel PM, Dankort DL, Hardy WR, Muller WJ: Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. Mol Cell Biol. 1994, 14: 7068-7077.
Article
CAS
PubMed
PubMed Central
Google Scholar
Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Butel JS, Bradley A: Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 1992, 356: 215-221. 10.1038/356215a0.
Article
CAS
PubMed
Google Scholar
BCM Search Launcher: Multiple Alignments. [http://searchlauncher.bcm.tmc.edu/multi-align/multi-align.html]
He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW: Identification of c-MYC as a target of the APC pathway. Science. 1998, 281: 1509-1512. 10.1126/science.281.5382.1509.
Article
CAS
PubMed
Google Scholar
Hamad NM, Elconin JH, Karnoub AE, Bai W, Rich JN, Abraham RT, Der CJ, Counter CM: Distinct requirements for Ras oncogenesis in human versus mouse cells. Genes Dev. 2002, 16: 2045-2057. 10.1101/gad.993902.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dankort D, Maslikowski B, Warner N, Kanno N, Kim H, Wang Z, Moran MF, Oshima RG, Cardiff RD, Muller WJ: Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer. Mol Cell Biol. 2001, 21: 1540-1551. 10.1128/MCB.21.5.1540-1551.2001.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dankort D, Jeyabalan N, Jones N, Dumont DJ, Muller WJ: Multiple ErbB-2/Neu Phosphorylation Sites Mediate Transformation through Distinct Effector Proteins. J Biol Chem. 2001, 276: 38921-38928. 10.1074/jbc.M106239200.
Article
CAS
PubMed
Google Scholar
Janes PW, Daly RJ, deFazio A, Sutherland RL: Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2. Oncogene. 1994, 9: 3601-3608.
CAS
PubMed
Google Scholar
Rosner A, Miyoshi K, Landesman-Bollag E, Xu X, Seldin DC, Moser AR, MacLeod CL, Shyamala G, Gillgrass AE, Cardiff RD: Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors. Am J Pathol. 2002, 161: 1087-1097.
Article
CAS
PubMed
PubMed Central
Google Scholar
Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ: Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci U S A. 1992, 89: 10578-10582.
Article
CAS
PubMed
PubMed Central
Google Scholar
Janda E, Litos G, Grunert S, Downward J, Beug H: Oncogenic Ras/Her-2 mediate hyperproliferation of polarized epithelial cells in 3D cultures and rapid tumor growth via the PI3K pathway. Oncogene. 2002, 21: 5148-5159. 10.1038/sj.onc.1205661.
Article
CAS
PubMed
Google Scholar
Daub H, Weiss FU, Wallasch C, Ullrich A: Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature. 1996, 379: 557-560. 10.1038/379557a0.
Article
CAS
PubMed
Google Scholar
Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, Donaher JL, Popescu NC, Hahn WC, Weinberg RA: Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 2001, 15: 50-65. 10.1101/gad.828901.
Article
CAS
PubMed
PubMed Central
Google Scholar
Johnson L, Mercer K, Greenbaum D, Bronson RT, Crowley D, Tuveson DA, Jacks T: Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature. 2001, 410: 1111-1116. 10.1038/35074129.
Article
CAS
PubMed
Google Scholar
Fisher GH, Wellen SL, Klimstra D, Lenczowski JM, Tichelaar JW, Lizak MJ, Whitsett JA, Koretsky A, Varmus HE: Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev. 2001, 15: 3249-3262. 10.1101/gad.947701.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wistuba , Gazdar AF, Minna JD: Molecular genetics of small cell lung carcinoma. Semin Oncol. 2001, 28: 3-13. 10.1053/sonc.2001.25738.
Article
CAS
PubMed
Google Scholar
Li D: Molecular epidemiology of pancreatic cancer. Cancer J. 2001, 7: 259-265.
CAS
PubMed
Google Scholar
Cho KR, Vogelstein B: Genetic alterations in the adenoma – carcinoma sequence. Cancer. 1992, 70: 1727-1731.
Article
CAS
PubMed
Google Scholar
Li B, Rosen JM, McMenamin-Balano J, Muller WJ, Perkins AS: neu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice. Mol Cell Biol. 1997, 17: 3155-3163.
Article
CAS
PubMed
PubMed Central
Google Scholar
Muller WJ, Arteaga CL, Muthuswamy SK, Siegel PM, Webster MA, Cardiff RD, Meise KS, Li F, Halter SA, Coffey RJ: Synergistic interaction of the Neu proto-oncogene product and transforming growth factor alpha in the mammary epithelium of transgenic mice. Mol Cell Biol. 1996, 16: 5726-5736.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jamora C, DasGupta R, Kocieniewski P, Fuchs E: Links between signal transduction, transcription and adhesion in epithelial bud development. Nature. 2003, 422: 317-322. 10.1038/nature01458.
Article
CAS
PubMed
PubMed Central
Google Scholar
Reya T, Duncan AW, Ailles L, Domen J, Scherer DC, Willert K, Hintz L, Nusse R, Weissman IL: A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature. 2003, 423: 409-414. 10.1038/nature01593.
Article
CAS
PubMed
Google Scholar
Willert K, Brown JD, Danenberg E, Duncan AW, Weissman IL, Reya T, Yates JR, Nusse R: Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature. 2003, 423: 448-452. 10.1038/nature01611.
Article
CAS
PubMed
Google Scholar
Sancho E, Batlle E, Clevers H: Live and let die in the intestinal epithelium. Curr Opin Cell Biol. 2003, 15: 763-770. 10.1016/j.ceb.2003.10.012.
Article
CAS
PubMed
Google Scholar